CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.
about
Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic PhenotypeNanoparticle analysis sheds budding insights into genetic drivers of extracellular vesicle biogenesis.Expression and Subcellular Distribution of GFP-Tagged Human Tetraspanin Proteins in Saccharomyces cerevisiaeIntegrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Comparative marker analysis of extracellular vesicles in different human cancer types.Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer.Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization.Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis.Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.CD63 inhibits the cell migration and invasion ability of tongue squamous cell carcinoma.
P2860
Q26776113-5F176B56-D0A0-4D0F-86B2-30102C734904Q27303163-842063E0-4F2C-4F85-B87D-80FD68EB5F72Q28546836-E549E505-DA2E-47F0-A3EF-3287DE815B6BQ34165070-A5741521-FF63-479C-B6E4-046E16839DE8Q34914039-C84C5A6B-61CD-46E4-815C-30EAD5939F7CQ37141154-9F359301-F302-4B41-AF91-37265B37993FQ38733777-A55FAB61-9469-47C9-B428-3E2FE5E6786BQ38944125-614DECC2-A51C-4A7E-8BC7-B8A9EBC7A767Q39986983-55796AAE-4585-490D-9F21-2C2397178EFDQ55059317-1249C14B-6D27-4871-B67B-702B4FDBE18EQ55355315-7656D200-73E4-4BEC-928C-39EAD6B36714
P2860
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.
@en
type
label
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.
@en
prefLabel
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.
@en
P2093
P1433
P1476
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.
@en
P2093
Hyun-Mi Kang
Kyo Young Lee
Mi Seon Kwon
Seon-Hee Yim
Seung-Hun Shin
Tae-Min Kim
Yeun-Jun Chung
P356
10.1016/J.LUNGCAN.2007.01.032
P577
2007-03-12T00:00:00Z